e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Lung tumour metastases, rare tumours paraneoplastic syndromes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis
O. F. Erer, P. Duru, A. Veral, G. Ari, S. A. Ozkan (Izmir, Turkey)
Source:
Annual Congress 2005 - Lung tumour metastases, rare tumours paraneoplastic syndromes
Session:
Lung tumour metastases, rare tumours paraneoplastic syndromes
Session type:
Thematic Poster Session
Number:
3478
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. F. Erer, P. Duru, A. Veral, G. Ari, S. A. Ozkan (Izmir, Turkey). A rare involvement in a male patient with non-small cell lung carcinoma: breast metastasis. Eur Respir J 2005; 26: Suppl. 49, 3478
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
How to treat a T1-T3N0 non-small cell lung cancer (NSCLC) with isolated brain metastasis
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
Influence of histological subtypes of bronchioloalveolar carcinoma on prognosis and treatment
Source: Annual Congress 2006 - Prognostic factors in lung cancer
Year: 2006
Breast metastasis in association with non-small cell lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 538s
Year: 2005
How to treat brain metastasis in patients with non-small cell lung carcinoma (NSCLC) and EGFR mutations
Source: International Congress 2015 – How to treat brain metastases
Year: 2015
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Metastatic disease in non-small cell lung cancer: is it all the same?
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017
A case of non-small cell lung carcinoma presenting with deltoid muscle metastases
Source: Eur Respir J 2006; 28: Suppl. 50, 76s
Year: 2006
A rare choroidal metastasis in ALK+ non-small cell lung cancer (NSCLC) that responds to Crizotinib
Source: International Congress 2019 – CCC Thoracic oncology
Year: 2019
Should there be a specific management for large cell neuroendocrine carcinoma?
Source: Annual Congress 2005 - Neuroendocrine tumours of the lung
Year: 2005
Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
Do cavitating non-small cell lung cancer patients have a more aggressive disease?
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006
Characteristics and survival analysis of synchronous oligometastatic non-small cell lung carcinoma.
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020
Survival and prognostic factors of oligometastatic non-small cell lung carcinoma: A single center experience
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017
Features of N-staging in left-sided non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006
Management of EGFR mutated nonsmall cell lung carcinoma patients
Source: Eur Respir J 2015; 45: 1132-1141
Year: 2015
Analysis of risk factors for brain metastasis in locally advanced stage non-small cell carcinoma
Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients
Year: 2010
Non-small cell lung cancer with single brain metastasis: the role of surgical treatment
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept